Get the Stockscreener App
14.39
1.30%
-0.19
After Hours:
14.39
Elanco Animal Health Inc stock is traded at $14.39, with a volume of 4.08M.
It is down -1.30% in the last 24 hours and up +0.70% over the past month.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
See More
Previous Close:
$14.58
Open:
$14.6
24h Volume:
4.08M
Relative Volume:
0.73
Market Cap:
$7.15B
Revenue:
$4.45B
Net Income/Loss:
$205.00M
P/E Ratio:
35.98
EPS:
0.4
Net Cash Flow:
$372.00M
1W Performance:
-3.62%
1M Performance:
+0.70%
6M Performance:
+17.09%
1Y Performance:
+11.29%
1-Day Range:
$14.28
$14.60
1-Week Range:
$14.28
$15.14
52-Week Range:
$8.02
$15.78
Elanco Animal Health Inc Stock (ELAN) Company Profile
Name
Elanco Animal Health Inc
Sector
Phone
877-352-6261
Address
2500 INNOVATION WAY, GREENFIELD
Compare ELAN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
14.39 | 7.24B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
151.01 | 67.12B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.32 | 45.19B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.57B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.54 | 18.93B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.56 | 13.45B | 2.99B | 1.21B | 1.13B | 25.06 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-26-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-09-24 | Initiated | UBS | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Market Perform |
| Sep-19-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-19-23 | Initiated | Jefferies | Buy |
| Dec-15-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Apr-20-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-18-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-16-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Sell |
| Jul-12-22 | Initiated | Piper Sandler | Neutral |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Oct-28-21 | Downgrade | Stifel | Buy → Hold |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jun-15-21 | Upgrade | Cleveland Research | Underperform → Neutral |
| May-11-21 | Upgrade | Barclays | Underweight → Equal Weight |
| May-11-21 | Upgrade | Gabelli & Co | Hold → Buy |
| Apr-15-21 | Initiated | Stifel | Buy |
| Mar-22-21 | Downgrade | Gabelli & Co | Buy → Hold |
| Feb-26-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-09-20 | Downgrade | Argus | Buy → Hold |
| Nov-09-20 | Downgrade | Barclays | Overweight → Underweight |
| Aug-20-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-13-20 | Resumed | Credit Suisse | Neutral |
| Aug-04-20 | Resumed | Goldman | Buy |
| Jul-27-20 | Downgrade | Cleveland Research | Neutral → Underperform |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Dec-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-07-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-19 | Initiated | Barclays | Overweight |
| Aug-26-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-15-19 | Upgrade | UBS | Sell → Neutral |
| May-23-19 | Initiated | Guggenheim | Neutral |
| Mar-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-13-19 | Resumed | Morgan Stanley | Equal-Weight |
| Feb-12-19 | Initiated | William Blair | Mkt Perform |
| Jan-23-19 | Initiated | UBS | Sell |
| Jan-15-19 | Initiated | Argus | Buy |
| Oct-15-18 | Initiated | Morgan Stanley | Equal-Weight |
View All
Elanco Animal Health Inc Stock (ELAN) Latest News
Sector Rotation Brings Elanco Animal Health Incorporated Into FocusMulti-Bagger Potential Stock Forecast Tools Released - beatles.ru
Animal Growth Promoter Market Size and Share Forecast Outlook - openPR.com
Fish Vaccine Market Generated Opportunities, Future Scope - openPR.com
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Bought by Victory Capital Management Inc. - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Allianz Asset Management GmbH Sells 317,192 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
European Commission approves Zenrelia - DVM360
Wyckoff Accumulation Phase Possible in Elanco Animal Health IncorporatedEntry Points For Growing Stocks Identified by Models - metal.it
Dogs Vaccines Market to Witness Comprehensive Growth by 2032 | - openPR.com
What are the latest earnings results for Elanco Animal Health IncorporatedLightning-fast capital gains - jammulinksnews.com
Universal Beteiligungs und Servicegesellschaft mbH Invests $5.70 Million in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Purchased by Envestnet Asset Management Inc. - MarketBeat
Does Elanco Animal Health Incorporated stock perform well during market downturnsBreakthrough profit margins - jammulinksnews.com
What institutional investors are buying Elanco Animal Health Incorporated stockExplosive trading growth - jammulinksnews.com
Equitable Trust Co. Purchases 24,129 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health (NYSE:ELAN) Price Target Raised to $18.00 - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Bought by Private Management Group Inc. - MarketBeat
Why Elanco (ELAN) Stock Is Trading Up Today - Yahoo Finance
Elanco Animal Health Incorporated Stock Analysis and ForecastLightning-fast capital gains - PrintWeekIndia
What drives Elanco Animal Health Incorporated stock priceLightning-fast growth - PrintWeekIndia
Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs - The Malaysian Reserve
Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs | ELAN Stock News - GuruFocus
EU Approval Boosts Elanco (ELAN) with Zenrelia Milestone | ELAN Stock News - GuruFocus
What analysts say about Elanco Animal Health Incorporated stockDynamic portfolio growth - PrintWeekIndia
ELAN vs. USPH: Which Stock Is the Better Value Option? - Yahoo Finance
Aquatic Veterinary Market Set to Witness Significant Growth - openPR.com
Jennison Associates LLC Sells 329,115 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health (ELAN): UBS Maintains Buy Rating, Raises Pr - GuruFocus
Autogenous Vaccine for Aquaculture Market Generated - openPR.com
ELANCO SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Elanco Animal Health Inc. (NYSE:ELAN) And Encourages Long-Term Investors to Contact the FirmELAN - ACCESS Newswire
Is Elanco Animal Health Incorporated a good long term investmentHigh-profit trading signals - jammulinksnews.com
Are Medical Stocks Lagging Encompass Health (EHC) This Year? - Yahoo Finance
Veterinary Oncology Market Growth in Future Scope 2025-2032 | - openPR.com
Veterinary DermatologyCompany Evaluation Report 2025 | Zoetis, Elanco, and Boehringer Ingelheim Dominate with Global Reach, Innovative Portfolios, and Strategic Expansion - Yahoo Finance
FY2025 Earnings Forecast for ELAN Issued By Leerink Partnrs - MarketBeat
Leerink Partnrs Has Strong Estimate for ELAN FY2027 Earnings - Defense World
Xponance Inc. Has $256,000 Stock Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
M&T Bank Corp Sells 1,445 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
DDD Partners LLC Has $15.68 Million Stock Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health (NYSE:ELAN) Raised to “Outperform” at Leerink Partners - Defense World
Elanco Animal Health (ELAN) Soars 1.34% on Upgrade - AInvest
Elanco Animal Health Inc Stock (ELAN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):